[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Europe Human Respiratory Syncytial Virus Drugs Market Report 2017

March 2017 | 122 pages | ID: ECCBD373DF8EN
QYResearch

US$ 3,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Notes:

Sales, means the sales volume of Human Respiratory Syncytial Virus Drugs

Revenue, means the sales value of Human Respiratory Syncytial Virus Drugs

This report studies sales (consumption) of Human Respiratory Syncytial Virus Drugs in Europe market, especially in Germany, France, UK, Russia, Italy, Spain and Benelux, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering
  • AstraZeneca
  • AbbVie
  • GSK
  • Teva Pharmaceutical
  • Ablynx
  • ADMA Biologics
  • Alnylam Pharmaceuticals
  • Ark Biosciences
  • Aviragen Therapeutics
  • Bavarian Nordic
  • Boehringer Ingelheim
  • Gilead Sciences
  • ImmunoVaccine Technologies
  • Johnson & Johnson
  • Kyowa Hakko Kirin
  • Medivir, Mucosis
  • Mymetics
  • Novavax
  • Regeneron Pharmaceuticals
  • ReViral
  • Vaxart
Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Human Respiratory Syncytial Virus Drugs in these countries, from 2011 to 2021 (forecast), like
  • Germany
  • France
  • UK
  • Russia
  • Italy
  • Spain
  • Benelux
Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into
  • Approved Drugs
  • Off-Label Drugs
Split by application, this report focuses on sales, market share and growth rate of Human Respiratory Syncytial Virus Drugs in each application, can be divided into
  • Hospitals
  • Clinics
Europe Human Respiratory Syncytial Virus Drugs Market Report 2017

1 HUMAN RESPIRATORY SYNCYTIAL VIRUS DRUGS OVERVIEW

1.1 Product Overview and Scope of Human Respiratory Syncytial Virus Drugs
1.2 Classification of Human Respiratory Syncytial Virus Drugs
  1.2.1 Approved Drugs
  1.2.2 Off-Label Drugs
1.3 Application of Human Respiratory Syncytial Virus Drugs
  1.3.1 Hospitals
  1.3.2 Clinics
1.4 Human Respiratory Syncytial Virus Drugs Market by Countries
  1.4.1 Germany Status and Prospect (2012-2022)
  1.4.2 France Status and Prospect (2012-2022)
  1.4.3 UK Status and Prospect (2012-2022)
  1.4.4 Russia Status and Prospect (2012-2022)
  1.4.5 Italy Status and Prospect (2012-2022)
  1.4.6 Spain Status and Prospect (2012-2022)
  1.4.7 Benelux Status and Prospect (2012-2022)
1.5 Europe Market Size (Value and Volume) of Human Respiratory Syncytial Virus Drugs (2012-2022)
  1.5.1 Europe Human Respiratory Syncytial Virus Drugs Sales and Growth Rate (2012-2022)
  1.5.2 Europe Human Respiratory Syncytial Virus Drugs Revenue and Growth Rate (2012-2022)

2 EUROPE HUMAN RESPIRATORY SYNCYTIAL VIRUS DRUGS BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Europe Human Respiratory Syncytial Virus Drugs Market Competition by Manufacturers
  2.1.1 Europe Human Respiratory Syncytial Virus Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)
  2.1.2 Europe Human Respiratory Syncytial Virus Drugs Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Human Respiratory Syncytial Virus Drugs (Volume and Value) by Type
  2.2.1 Europe Human Respiratory Syncytial Virus Drugs Sales and Market Share by Type (2012-2017)
  2.2.2 Europe Human Respiratory Syncytial Virus Drugs Revenue and Market Share by Type (2012-2017)
2.3 Europe Human Respiratory Syncytial Virus Drugs (Volume and Value) by Countries
  2.3.1 Europe Human Respiratory Syncytial Virus Drugs Sales and Market Share by Countries (2012-2017)
  2.3.2 Europe Human Respiratory Syncytial Virus Drugs Revenue and Market Share by Countries (2012-2017)
2.4 Europe Human Respiratory Syncytial Virus Drugs (Volume) by Application

3 GERMANY HUMAN RESPIRATORY SYNCYTIAL VIRUS DRUGS (VOLUME, VALUE AND SALES PRICE)

3.1 Germany Human Respiratory Syncytial Virus Drugs Sales and Value (2012-2017)
  3.1.1 Germany Human Respiratory Syncytial Virus Drugs Sales and Growth Rate (2012-2017)
  3.1.2 Germany Human Respiratory Syncytial Virus Drugs Revenue and Growth Rate (2012-2017)
  3.1.3 Germany Human Respiratory Syncytial Virus Drugs Sales Price Trend (2012-2017)
3.2 Germany Human Respiratory Syncytial Virus Drugs Sales and Market Share by Manufacturers
3.3 Germany Human Respiratory Syncytial Virus Drugs Sales and Market Share by Type
3.4 Germany Human Respiratory Syncytial Virus Drugs Sales and Market Share by Application

4 FRANCE HUMAN RESPIRATORY SYNCYTIAL VIRUS DRUGS (VOLUME, VALUE AND SALES PRICE)

4.1 France Human Respiratory Syncytial Virus Drugs Sales and Value (2012-2017)
  4.1.1 France Human Respiratory Syncytial Virus Drugs Sales and Growth Rate (2012-2017)
  4.1.2 France Human Respiratory Syncytial Virus Drugs Revenue and Growth Rate (2012-2017)
  4.1.4 France Human Respiratory Syncytial Virus Drugs Sales Price Trend (2012-2017)
4.2 France Human Respiratory Syncytial Virus Drugs Sales and Market Share by Manufacturers
4.3 France Human Respiratory Syncytial Virus Drugs Sales and Market Share by Type
4.4 France Human Respiratory Syncytial Virus Drugs Sales and Market Share by Application

5 UK HUMAN RESPIRATORY SYNCYTIAL VIRUS DRUGS (VOLUME, VALUE AND SALES PRICE)

5.1 UK Human Respiratory Syncytial Virus Drugs Sales and Value (2012-2017)
  5.1.1 UK Human Respiratory Syncytial Virus Drugs Sales and Growth Rate (2012-2017)
  5.1.2 UK Human Respiratory Syncytial Virus Drugs Revenue and Growth Rate (2012-2017)
  5.1.5 UK Human Respiratory Syncytial Virus Drugs Sales Price Trend (2012-2017)
5.2 UK Human Respiratory Syncytial Virus Drugs Sales and Market Share by Manufacturers
5.3 UK Human Respiratory Syncytial Virus Drugs Sales and Market Share by Type
5.4 UK Human Respiratory Syncytial Virus Drugs Sales and Market Share by Application

6 RUSSIA HUMAN RESPIRATORY SYNCYTIAL VIRUS DRUGS (VOLUME, VALUE AND SALES PRICE)

6.1 Russia Human Respiratory Syncytial Virus Drugs Sales and Value (2012-2017)
  6.1.1 Russia Human Respiratory Syncytial Virus Drugs Sales and Growth Rate (2012-2017)
  6.1.2 Russia Human Respiratory Syncytial Virus Drugs Revenue and Growth Rate (2012-2017)
  6.1.6 Russia Human Respiratory Syncytial Virus Drugs Sales Price Trend (2012-2017)
6.2 Russia Human Respiratory Syncytial Virus Drugs Sales and Market Share by Manufacturers
6.3 Russia Human Respiratory Syncytial Virus Drugs Sales and Market Share by Type
6.4 Russia Human Respiratory Syncytial Virus Drugs Sales and Market Share by Application

7 ITALY HUMAN RESPIRATORY SYNCYTIAL VIRUS DRUGS (VOLUME, VALUE AND SALES PRICE)

7.1 Italy Human Respiratory Syncytial Virus Drugs Sales and Value (2012-2017)
  7.1.1 Italy Human Respiratory Syncytial Virus Drugs Sales and Growth Rate (2012-2017)
  7.1.2 Italy Human Respiratory Syncytial Virus Drugs Revenue and Growth Rate (2012-2017)
  7.1.7 Italy Human Respiratory Syncytial Virus Drugs Sales Price Trend (2012-2017)
7.2 Italy Human Respiratory Syncytial Virus Drugs Sales and Market Share by Manufacturers
7.3 Italy Human Respiratory Syncytial Virus Drugs Sales and Market Share by Type
7.4 Italy Human Respiratory Syncytial Virus Drugs Sales and Market Share by Application

8 SPAIN HUMAN RESPIRATORY SYNCYTIAL VIRUS DRUGS (VOLUME, VALUE AND SALES PRICE)

8.1 Spain Human Respiratory Syncytial Virus Drugs Sales and Value (2012-2017)
  8.1.1 Spain Human Respiratory Syncytial Virus Drugs Sales and Growth Rate (2012-2017)
  8.1.2 Spain Human Respiratory Syncytial Virus Drugs Revenue and Growth Rate (2012-2017)
  8.1.8 Spain Human Respiratory Syncytial Virus Drugs Sales Price Trend (2012-2017)
8.2 Spain Human Respiratory Syncytial Virus Drugs Sales and Market Share by Manufacturers
8.3 Spain Human Respiratory Syncytial Virus Drugs Sales and Market Share by Type
8.4 Spain Human Respiratory Syncytial Virus Drugs Sales and Market Share by Application

9 BENELUX HUMAN RESPIRATORY SYNCYTIAL VIRUS DRUGS (VOLUME, VALUE AND SALES PRICE)

9.1 Benelux Human Respiratory Syncytial Virus Drugs Sales and Value (2012-2017)
  9.1.1 Benelux Human Respiratory Syncytial Virus Drugs Sales and Growth Rate (2012-2017)
  9.1.2 Benelux Human Respiratory Syncytial Virus Drugs Revenue and Growth Rate (2012-2017)
  9.1.9 Benelux Human Respiratory Syncytial Virus Drugs Sales Price Trend (2012-2017)
9.2 Benelux Human Respiratory Syncytial Virus Drugs Sales and Market Share by Manufacturers
9.3 Benelux Human Respiratory Syncytial Virus Drugs Sales and Market Share by Type
9.4 Benelux Human Respiratory Syncytial Virus Drugs Sales and Market Share by Application

10 EUROPE HUMAN RESPIRATORY SYNCYTIAL VIRUS DRUGS MANUFACTURERS ANALYSIS

10.1 AstraZeneca
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Human Respiratory Syncytial Virus Drugs Product Type, Application and Specification
    10.1.2.1 Product A
    10.1.2.2 Product B
  10.1.3 AstraZeneca Human Respiratory Syncytial Virus Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.1.4 Main Business/Business Overview
10.2 AbbVie
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Human Respiratory Syncytial Virus Drugs Product Type, Application and Specification
    10.2.2.1 Product A
    10.2.2.2 Product B
  10.2.3 AbbVie Human Respiratory Syncytial Virus Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.2.4 Main Business/Business Overview
10.3 GSK
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Human Respiratory Syncytial Virus Drugs Product Type, Application and Specification
    10.3.2.1 Product A
    10.3.2.2 Product B
  10.3.3 GSK Human Respiratory Syncytial Virus Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.3.4 Main Business/Business Overview
10.4 Teva Pharmaceutical
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Human Respiratory Syncytial Virus Drugs Product Type, Application and Specification
    10.4.2.1 Product A
    10.4.2.2 Product B
  10.4.3 Teva Pharmaceutical Human Respiratory Syncytial Virus Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.4.4 Main Business/Business Overview
10.5 Ablynx
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Human Respiratory Syncytial Virus Drugs Product Type, Application and Specification
    10.5.2.1 Product A
    10.5.2.2 Product B
  10.5.3 Ablynx Human Respiratory Syncytial Virus Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.5.4 Main Business/Business Overview
10.6 ADMA Biologics
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Human Respiratory Syncytial Virus Drugs Product Type, Application and Specification
    10.6.2.1 Product A
    10.6.2.2 Product B
  10.6.3 ADMA Biologics Human Respiratory Syncytial Virus Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.6.4 Main Business/Business Overview
10.7 Alnylam Pharmaceuticals
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Human Respiratory Syncytial Virus Drugs Product Type, Application and Specification
    10.7.2.1 Product A
    10.7.2.2 Product B
  10.7.3 Alnylam Pharmaceuticals Human Respiratory Syncytial Virus Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.7.4 Main Business/Business Overview
10.8 Ark Biosciences
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Human Respiratory Syncytial Virus Drugs Product Type, Application and Specification
    10.8.2.1 Product A
    10.8.2.2 Product B
  10.8.3 Ark Biosciences Human Respiratory Syncytial Virus Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.8.4 Main Business/Business Overview
10.9 Aviragen Therapeutics
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Human Respiratory Syncytial Virus Drugs Product Type, Application and Specification
    10.9.2.1 Product A
    10.9.2.2 Product B
  10.9.3 Aviragen Therapeutics Human Respiratory Syncytial Virus Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.9.4 Main Business/Business Overview
10.10 Bavarian Nordic
  10.10.1 Company Basic Information, Manufacturing Base and Competitors
  10.10.2 Human Respiratory Syncytial Virus Drugs Product Type, Application and Specification
    10.10.2.1 Product A
    10.10.2.2 Product B
  10.10.3 Bavarian Nordic Human Respiratory Syncytial Virus Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.10.4 Main Business/Business Overview
10.11 Boehringer Ingelheim
10.12 Gilead Sciences
10.13 ImmunoVaccine Technologies
10.14 Johnson & Johnson
10.15 Kyowa Hakko Kirin
10.16 Medivir, Mucosis
10.17 Mymetics
10.18 Novavax
10.19 Regeneron Pharmaceuticals
10.20 ReViral
10.21 Vaxart

11 HUMAN RESPIRATORY SYNCYTIAL VIRUS DRUGS MANUFACTURING COST ANALYSIS

11.1 Human Respiratory Syncytial Virus Drugs Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Human Respiratory Syncytial Virus Drugs

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Human Respiratory Syncytial Virus Drugs Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Human Respiratory Syncytial Virus Drugs Major Manufacturers in 2015
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 EUROPE HUMAN RESPIRATORY SYNCYTIAL VIRUS DRUGS MARKET FORECAST (2017-2022)

14.1 Germany Human Respiratory Syncytial Virus Drugs Sales Forecast (2017-2022)
14.2 France Human Respiratory Syncytial Virus Drugs Sales Forecast (2017-2022)
14.3 UK Human Respiratory Syncytial Virus Drugs Sales Forecast (2017-2022)
14.4 Russia Human Respiratory Syncytial Virus Drugs Sales Forecast (2017-2022)
14.5 Italy Human Respiratory Syncytial Virus Drugs Sales Forecast (2017-2022)
14.6 Spain Human Respiratory Syncytial Virus Drugs Sales Forecast (2017-2022)
14.7 Benelux Human Respiratory Syncytial Virus Drugs Sales Forecast (2017-2022)
14.8 Europe Human Respiratory Syncytial Virus Drugs Sales Forecast by Type (2017-2022)
14.9 Europe Human Respiratory Syncytial Virus Drugs Sales Forecast by Application (2017-2022)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Picture of Human Respiratory Syncytial Virus Drugs
Table Classification of Human Respiratory Syncytial Virus Drugs
Figure Europe Sales Market Share of Human Respiratory Syncytial Virus Drugs by Type in 2015
Figure Approved Drugs Picture
Figure Off-Label Drugs Picture
Table Application of Human Respiratory Syncytial Virus Drugs
Figure Europe Sales Market Share of Human Respiratory Syncytial Virus Drugs by Application in 2015
Figure Hospitals Examples
Figure Clinics Examples
Figure Germany Human Respiratory Syncytial Virus Drugs Revenue and Growth Rate (2012-2022)
Figure France Human Respiratory Syncytial Virus Drugs Revenue and Growth Rate (2012-2022)
Figure UK Human Respiratory Syncytial Virus Drugs Revenue and Growth Rate (2012-2022)
Figure Russia Human Respiratory Syncytial Virus Drugs Revenue and Growth Rate (2012-2022)
Figure Italy Human Respiratory Syncytial Virus Drugs Revenue and Growth Rate (2012-2022)
Figure Spain Human Respiratory Syncytial Virus Drugs Revenue and Growth Rate (2012-2022)
Figure Benelux Human Respiratory Syncytial Virus Drugs Revenue and Growth Rate (2012-2022)
Figure Europe Human Respiratory Syncytial Virus Drugs Sales and Growth Rate (2012-2022)
Figure Europe Human Respiratory Syncytial Virus Drugs Revenue and Growth Rate (2012-2022)
Table Europe Human Respiratory Syncytial Virus Drugs Sales of Key Manufacturers (2015 and 2016)
Table Europe Human Respiratory Syncytial Virus Drugs Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Human Respiratory Syncytial Virus Drugs Sales Share by Manufacturers
Figure 2016 Human Respiratory Syncytial Virus Drugs Sales Share by Manufacturers
Table Europe Human Respiratory Syncytial Virus Drugs Revenue by Manufacturers (2015 and 2016)
Table Europe Human Respiratory Syncytial Virus Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Human Respiratory Syncytial Virus Drugs Revenue Share by Manufacturers
Table 2016 Europe Human Respiratory Syncytial Virus Drugs Revenue Share by Manufacturers
Table Europe Human Respiratory Syncytial Virus Drugs Sales and Market Share by Type (2012-2017)
Table Europe Human Respiratory Syncytial Virus Drugs Sales Share by Type (2012-2017)
Figure Sales Market Share of Human Respiratory Syncytial Virus Drugs by Type (2012-2017)
Figure Europe Human Respiratory Syncytial Virus Drugs Sales Growth Rate by Type (2012-2017)
Table Europe Human Respiratory Syncytial Virus Drugs Revenue and Market Share by Type (2012-2017)
Table Europe Human Respiratory Syncytial Virus Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Human Respiratory Syncytial Virus Drugs by Type (2012-2017)
Figure Europe Human Respiratory Syncytial Virus Drugs Revenue Growth Rate by Type (2012-2017)
Table Europe Human Respiratory Syncytial Virus Drugs Sales and Market Share by Countries (2012-2017)
Table Europe Human Respiratory Syncytial Virus Drugs Sales Share by Countries (2012-2017)
Figure Sales Market Share of Human Respiratory Syncytial Virus Drugs by Countries (2012-2017)
Table Europe Human Respiratory Syncytial Virus Drugs Revenue and Market Share by Countries (2012-2017)
Table Europe Human Respiratory Syncytial Virus Drugs Revenue Share by Countries (2012-2017)
Figure Revenue Market Share of Human Respiratory Syncytial Virus Drugs by Countries (2012-2017)
Table Europe Human Respiratory Syncytial Virus Drugs Sales and Market Share by Application (2012-2017)
Table Europe Human Respiratory Syncytial Virus Drugs Sales Share by Application (2012-2017)
Figure Sales Market Share of Human Respiratory Syncytial Virus Drugs by Application (2012-2017)
Figure Germany Human Respiratory Syncytial Virus Drugs Sales and Growth Rate (2012-2017)
Figure Germany Human Respiratory Syncytial Virus Drugs Revenue and Growth Rate (2012-2017)
Figure Germany Human Respiratory Syncytial Virus Drugs Sales Price Trend (2012-2017)
Table Germany Human Respiratory Syncytial Virus Drugs Sales by Manufacturers (2015 and 2016)
Table Germany Human Respiratory Syncytial Virus Drugs Market Share by Manufacturers (2015 and 2016)
Table Germany Human Respiratory Syncytial Virus Drugs Sales by Type (2015 and 2016)
Table Germany Human Respiratory Syncytial Virus Drugs Market Share by Type (2015 and 2016)
Table Germany Human Respiratory Syncytial Virus Drugs Sales by Application (2015 and 2016)
Table Germany Human Respiratory Syncytial Virus Drugs Market Share by Application (2015 and 2016)
Figure France Human Respiratory Syncytial Virus Drugs Sales and Growth Rate (2012-2017)
Figure France Human Respiratory Syncytial Virus Drugs Revenue and Growth Rate (2012-2017)
Figure France Human Respiratory Syncytial Virus Drugs Sales Price Trend (2012-2017)
Table France Human Respiratory Syncytial Virus Drugs Sales by Manufacturers (2015 and 2016)
Table France Human Respiratory Syncytial Virus Drugs Market Share by Manufacturers (2015 and 2016)
Table France Human Respiratory Syncytial Virus Drugs Sales by Type (2015 and 2016)
Table France Human Respiratory Syncytial Virus Drugs Market Share by Type (2015 and 2016)
Table France Human Respiratory Syncytial Virus Drugs Sales by Application (2015 and 2016)
Table France Human Respiratory Syncytial Virus Drugs Market Share by Application (2015 and 2016)
Figure UK Human Respiratory Syncytial Virus Drugs Sales and Growth Rate (2012-2017)
Figure UK Human Respiratory Syncytial Virus Drugs Revenue and Growth Rate (2012-2017)
Figure UK Human Respiratory Syncytial Virus Drugs Sales Price Trend (2012-2017)
Table UK Human Respiratory Syncytial Virus Drugs Sales by Manufacturers (2015 and 2016)
Table UK Human Respiratory Syncytial Virus Drugs Market Share by Manufacturers (2015 and 2016)
Table UK Human Respiratory Syncytial Virus Drugs Sales by Type (2015 and 2016)
Table UK Human Respiratory Syncytial Virus Drugs Market Share by Type (2015 and 2016)
Table UK Human Respiratory Syncytial Virus Drugs Sales by Application (2015 and 2016)
Table UK Human Respiratory Syncytial Virus Drugs Market Share by Application (2015 and 2016)
Figure Russia Human Respiratory Syncytial Virus Drugs Sales and Growth Rate (2012-2017)
Figure Russia Human Respiratory Syncytial Virus Drugs Revenue and Growth Rate (2012-2017)
Figure Russia Human Respiratory Syncytial Virus Drugs Sales Price Trend (2012-2017)
Table Russia Human Respiratory Syncytial Virus Drugs Sales by Manufacturers (2015 and 2016)
Table Russia Human Respiratory Syncytial Virus Drugs Market Share by Manufacturers (2015 and 2016)
Table Russia Human Respiratory Syncytial Virus Drugs Sales by Type (2015 and 2016)
Table Russia Human Respiratory Syncytial Virus Drugs Market Share by Type (2015 and 2016)
Table Russia Human Respiratory Syncytial Virus Drugs Sales by Application (2015 and 2016)
Table Russia Human Respiratory Syncytial Virus Drugs Market Share by Application (2015 and 2016)
Figure Italy Human Respiratory Syncytial Virus Drugs Sales and Growth Rate (2012-2017)
Figure Italy Human Respiratory Syncytial Virus Drugs Revenue and Growth Rate (2012-2017)
Figure Italy Human Respiratory Syncytial Virus Drugs Sales Price Trend (2012-2017)
Table Italy Human Respiratory Syncytial Virus Drugs Sales by Manufacturers (2015 and 2016)
Table Italy Human Respiratory Syncytial Virus Drugs Market Share by Manufacturers (2015 and 2016)
Table Italy Human Respiratory Syncytial Virus Drugs Sales by Type (2015 and 2016)
Table Italy Human Respiratory Syncytial Virus Drugs Market Share by Type (2015 and 2016)
Table Italy Human Respiratory Syncytial Virus Drugs Sales by Application (2015 and 2016)
Table Italy Human Respiratory Syncytial Virus Drugs Market Share by Application (2015 and 2016)
Figure Spain Human Respiratory Syncytial Virus Drugs Sales and Growth Rate (2012-2017)
Figure Spain Human Respiratory Syncytial Virus Drugs Revenue and Growth Rate (2012-2017)
Figure Spain Human Respiratory Syncytial Virus Drugs Sales Price Trend (2012-2017)
Table Spain Human Respiratory Syncytial Virus Drugs Sales by Manufacturers (2015 and 2016)
Table Spain Human Respiratory Syncytial Virus Drugs Market Share by Manufacturers (2015 and 2016)
Table Spain Human Respiratory Syncytial Virus Drugs Sales by Type (2015 and 2016)
Table Spain Human Respiratory Syncytial Virus Drugs Market Share by Type (2015 and 2016)
Table Spain Human Respiratory Syncytial Virus Drugs Sales by Application (2015 and 2016)
Table Spain Human Respiratory Syncytial Virus Drugs Market Share by Application (2015 and 2016)
Figure Benelux Human Respiratory Syncytial Virus Drugs Sales and Growth Rate (2012-2017)
Figure Benelux Human Respiratory Syncytial Virus Drugs Revenue and Growth Rate (2012-2017)
Figure Benelux Human Respiratory Syncytial Virus Drugs Sales Price Trend (2012-2017)
Table Benelux Human Respiratory Syncytial Virus Drugs Sales by Manufacturers (2015 and 2016)
Table Benelux Human Respiratory Syncytial Virus Drugs Market Share by Manufacturers (2015 and 2016)
Table Benelux Human Respiratory Syncytial Virus Drugs Sales by Type (2015 and 2016)
Table Benelux Human Respiratory Syncytial Virus Drugs Market Share by Type (2015 and 2016)
Table Benelux Human Respiratory Syncytial Virus Drugs Sales by Application (2015 and 2016)
Table Benelux Human Respiratory Syncytial Virus Drugs Market Share by Application (2015 and 2016)
Table Human Respiratory Syncytial Virus Drugs Basic Information List
Table AstraZeneca Human Respiratory Syncytial Virus Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure AstraZeneca Human Respiratory Syncytial Virus Drugs Sales Market Share (2012-2017)
Table AbbVie Basic Information List
Table AbbVie Human Respiratory Syncytial Virus Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table AbbVie Human Respiratory Syncytial Virus Drugs Sales Market Share (2012-2017)
Table GSK Basic Information List
Table GSK Human Respiratory Syncytial Virus Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table GSK Human Respiratory Syncytial Virus Drugs Sales Market Share (2012-2017)
Table Teva Pharmaceutical Basic Information List
Table Teva Pharmaceutical Human Respiratory Syncytial Virus Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Teva Pharmaceutical Human Respiratory Syncytial Virus Drugs Sales Market Share (2012-2017)
Table Ablynx Basic Information List
Table Ablynx Human Respiratory Syncytial Virus Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Ablynx Human Respiratory Syncytial Virus Drugs Sales Market Share (2012-2017)
Table ADMA Biologics Basic Information List
Table ADMA Biologics Human Respiratory Syncytial Virus Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table ADMA Biologics Human Respiratory Syncytial Virus Drugs Sales Market Share (2012-2017)
Table Alnylam Pharmaceuticals Basic Information List
Table Alnylam Pharmaceuticals Human Respiratory Syncytial Virus Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Alnylam Pharmaceuticals Human Respiratory Syncytial Virus Drugs Sales Market Share (2012-2017)
Table Ark Biosciences Basic Information List
Table Ark Biosciences Human Respiratory Syncytial Virus Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Ark Biosciences Human Respiratory Syncytial Virus Drugs Sales Market Share (2012-2017)
Table Aviragen Therapeutics Basic Information List
Table Aviragen Therapeutics Human Respiratory Syncytial Virus Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Aviragen Therapeutics Human Respiratory Syncytial Virus Drugs Sales Market Share (2012-2017)
Table Bavarian Nordic Basic Information List
Table Bavarian Nordic Human Respiratory Syncytial Virus Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Bavarian Nordic Human Respiratory Syncytial Virus Drugs Sales Market Share (2012-2017)
Table Boehringer Ingelheim Basic Information List
Table Gilead Sciences Basic Information List
Table ImmunoVaccine Technologies Basic Information List
Table Johnson & Johnson Basic Information List
Table Kyowa Hakko Kirin Basic Information List
Table Medivir, Mucosis Basic Information List
Table Mymetics Basic Information List
Table Novavax Basic Information List
Table Regeneron Pharmaceuticals Basic Information List
Table ReViral Basic Information List
Table Vaxart Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Human Respiratory Syncytial Virus Drugs
Figure Manufacturing Process Analysis of Human Respiratory Syncytial Virus Drugs
Figure Human Respiratory Syncytial Virus Drugs Industrial Chain Analysis
Table Raw Materials Sources of Human Respiratory Syncytial Virus Drugs Major Manufacturers in 2015
Table Major Buyers of Human Respiratory Syncytial Virus Drugs
Table Distributors/Traders List
Figure Germany Human Respiratory Syncytial Virus Drugs Sales and Growth Rate Forecast (2017-2022)
Figure Germany Human Respiratory Syncytial Virus Drugs Revenue and Growth Rate Forecast (2017-2022)
Figure France Human Respiratory Syncytial Virus Drugs Sales and Growth Rate Forecast (2017-2022)
Figure France Human Respiratory Syncytial Virus Drugs Revenue and Growth Rate Forecast (2017-2022)
Figure UK Human Respiratory Syncytial Virus Drugs Sales and Growth Rate Forecast (2017-2022)
Figure UK Human Respiratory Syncytial Virus Drugs Revenue and Growth Rate Forecast (2017-2022)
Figure Russia Human Respiratory Syncytial Virus Drugs Sales and Growth Rate Forecast (2017-2022)
Figure Russia Human Respiratory Syncytial Virus Drugs Revenue and Growth Rate Forecast (2017-2022)
Figure Italy Human Respiratory Syncytial Virus Drugs Sales and Growth Rate Forecast (2017-2022)
Figure Italy Human Respiratory Syncytial Virus Drugs Revenue and Growth Rate Forecast (2017-2022)
Figure Spain Human Respiratory Syncytial Virus Drugs Sales and Growth Rate Forecast (2017-2022)
Figure Spain Human Respiratory Syncytial Virus Drugs Revenue and Growth Rate Forecast (2017-2022)
Figure Benelux Human Respiratory Syncytial Virus Drugs Sales and Growth Rate Forecast (2017-2022)
Figure Benelux Human Respiratory Syncytial Virus Drugs Revenue and Growth Rate Forecast (2017-2022)
Table Europe Human Respiratory Syncytial Virus Drugs Sales Forecast by Type (2017-2022)
Table Europe Human Respiratory Syncytial Virus Drugs Sales Forecast by Application (2017-2022)

More Publications

Need Help?

Ask a Question

Market Reports

All Categories